Docebo Inc. filings document the regulatory disclosures of a Canadian operating company listed on Nasdaq and the Toronto Stock Exchange. Its Form 6-K reports include IFRS interim financial statements, management discussion and analysis, earnings releases, Canadian executive certifications and XBRL exhibits tied to operating and financial results.
The filing record also covers annual general meeting materials, management information circulars, proxy solicitation and shareholder voting matters. Other disclosures address investor presentations, registration statement incorporation by reference, material-event reports, capital-structure matters and common-share repurchase activity, including substantial issuer bid documentation and related governance information.
Docebo Inc. reported Q1 2026 revenue of $65.6 million, up from $57.3 million, driven mainly by subscription revenue of $60.6 million. Annual Recurring Revenue reached $248.9 million, a 10.6% increase, and Average Contract Value rose to $71,000.
The company posted a net loss of $1.6 million versus net income of $1.5 million a year earlier, as operating expenses, foreign exchange losses, acquisition-related items and a $6.2 million workforce reduction more than offset higher gross profit. Adjusted EBITDA improved to $11.0 million, or 16.8% of revenue.
Docebo completed the $61.3 million acquisition of 365Talents, adding AI-powered skills intelligence capabilities and generating $1.8 million of revenue but a $1.4 million net loss since acquisition. It also drew $80 million on its revolving credit facility, repurchased about $63.1 million of shares (including a $60 million substantial issuer bid), and ended the quarter with $63.2 million in cash and a small equity deficit of $0.6 million.
Docebo Inc. has called a virtual-only annual general meeting for June 9, 2026, where shareholders will receive 2025 financial statements, elect seven directors and reappoint KPMG as auditor. Holders of 25,702,220 common shares as of April 20, 2026 may vote.
In a letter to shareholders, management highlights 2025 total revenue of $242.7 million, a 12.0% year-over-year increase, and 12.5% growth in Annual Recurring Revenue excluding its largest OEM wind-down. Fourth-quarter 2025 Adjusted EBITDA margin reached 21.2%, and the company references a $60 million share repurchase program.
Docebo Inc. used an investor briefing to showcase its AI-driven Workforce Readiness Platform and update its 2026 financial outlook. The company highlights a transition to an “Agentic Era,” positioning itself as a closed-loop learning, knowledge and skills platform built on a proprietary data layer and products like AgentHub, Model Context Protocol and Enterprise Knowledge.
Management cites a 19% total ARR CAGR from 2021‑2025 and a preliminary ARR estimate for the quarter ended March 31, 2026, alongside an ARR growth re-acceleration. For 2026, Docebo targets an adjusted EBITDA margin of about 20.5% and focuses on disciplined dilution. The addressable market is estimated to expand from $25 billion in 2023 to roughly $40 billion in 2026, including corporate learning, skills intelligence and U.S. government opportunities.
Guidance for the fiscal year ending December 31, 2026 was raised, with revenue now guided to $271–$273 million and adjusted EBITDA to $54–$56 million, up from prior ranges of $267–$269 million and $52–$54 million. The target operating model calls for double-digit revenue growth driven by improved new customer adds, net retention and efficiency gains in sales, marketing, R&D and G&A.
Docebo Inc. released preliminary unaudited results showing a strong start to 2026. Q1-2026 total revenue is expected between US$65.4–65.6 million, up 14.3% from US$57.3 million a year earlier, reflecting solid demand for its AI workforce readiness platform. Preliminary Adjusted EBITDA is projected at US$10.8–11.0 million, up 22.5% from US$8.9 million, indicating improving profitability. Annual Recurring Revenue (ARR) is expected at US$248.9 million as of March 31, 2026, a 10.6% increase despite a US$1.4 million foreign exchange headwind. Revenue concentration is easing, with the largest OEM customer expected to represent 3.2% of ARR versus 9.4% a year earlier. For full-year 2026, Docebo raised guidance, targeting total revenue of US$271.0–273.0 million, subscription revenue of US$253.5–255.5 million, and Adjusted EBITDA of US$54.5–56.5 million, all modestly above prior ranges.
Docebo Inc. released preliminary unaudited results showing a strong start to 2026. Q1-2026 total revenue is expected between US$65.4–65.6 million, up 14.3% from US$57.3 million a year earlier, reflecting solid demand for its AI workforce readiness platform. Preliminary Adjusted EBITDA is projected at US$10.8–11.0 million, up 22.5% from US$8.9 million, indicating improving profitability. Annual Recurring Revenue (ARR) is expected at US$248.9 million as of March 31, 2026, a 10.6% increase despite a US$1.4 million foreign exchange headwind. Revenue concentration is easing, with the largest OEM customer expected to represent 3.2% of ARR versus 9.4% a year earlier. For full-year 2026, Docebo raised guidance, targeting total revenue of US$271.0–273.0 million, subscription revenue of US$253.5–255.5 million, and Adjusted EBITDA of US$54.5–56.5 million, all modestly above prior ranges.
Docebo Inc. received an ownership update from major shareholder Intercap Inc. and its founder Jason Chapnik. Docebo ran a substantial issuer bid that expired on March 10, 2026, under which Intercap was expected to have 372,612 common shares repurchased at US$20.40 per share, for US$7,601,284.80 in cash.
After this transaction, Chapnik is deemed to beneficially own 15,945,759 common shares, or 61.7% of the company, including 32,407 shares issuable from vested deferred share units. Intercap beneficially owns 15,913,352 common shares, or 61.6%, based on 25,819,890 shares outstanding upon expiration of the offer, so they remain controlling shareholders.
Docebo Inc. reported the preliminary results of its substantial issuer bid to repurchase common shares. The company expects to buy for cancellation 2,941,176 Common Shares at US$20.40 per share, for aggregate consideration of US$60,000,000.
The shares expected to be purchased represent approximately 10.2% of issued and outstanding Common Shares on a non-diluted basis as of February 1, 2026. After the transaction, approximately 25,819,890 Common Shares are expected to be issued and outstanding.
The offer was oversubscribed, with shareholders (other than odd-lot holders) expected to have about 74.52% of their successfully tendered shares purchased. Intercap Inc. is expected to have 372,612 shares acquired under the offer and to beneficially own 15,913,352 shares, or about 61.6% of the company, following completion.
Docebo Inc. reported strong Q4 and full-year 2025 results and confirmed a sizable share repurchase offer. Q4 revenue was $63.0M, up 10.5%, with subscription revenue of $59.1M up 9.5% and representing 94% of total revenue. Net income jumped to $26.9M from $11.9M, while Adjusted EBITDA rose to $13.3M with a 21.2% margin. ARR reached $238.1M, up 8.4%, and the largest OEM customer declined to 4.4% of ARR from 9.5%.
For 2025, revenue was $242.7M, up 11.9%, with net income of $37.5M and Adjusted EBITDA of $43.9M, up 30.6%. The company reaffirmed its AI-first, multi-product strategy and highlighted several large enterprise and public-sector wins. Docebo waived the share price condition on its substantial issuer bid to repurchase up to $60M of shares at $20.40, with expiry on March 10, 2026. Guidance for 2026 calls for total revenue of $267.5M–$269.5M and Adjusted EBITDA of $52.5M–$54.5M.
Docebo Inc. files its Annual Report on Form 40-F, providing audited financial statements and governance disclosures for the fiscal year ended December 31, 2025. The filing incorporates the Annual Information Form, audited consolidated financial statements and MD&A as Exhibits 99.1, 99.2 and 99.3, and includes KPMG LLP’s attestation on internal control over financial reporting.
The company reports 28,747,289 common shares outstanding as of December 31, 2025, describes applicable Nasdaq/TSX governance elections, and files executive certifications and related exhibits dated February 27, 2026.
Docebo Inc. is moving ahead with a substantial issuer bid to repurchase for cancellation up to US$60,000,000 of its common shares at US$20.40 per share. This transaction lets shareholders sell shares back to the company at a fixed premium-style price.
Major shareholder Intercap Equity Inc., which beneficially owns about 56.6% of Docebo’s outstanding common shares (including a committed acquisition from WPGG 14 Investment Ltd. IV), now indicates it may tender shares in order to maintain its approximate ownership level. Docebo’s board continues to back the bid, stating the current trading price does not fully reflect the company’s value and future prospects.
To finance the repurchase, Docebo plans to use roughly US$30,000,000 of cash on hand and draw about US$30,000,000 from its credit facility. The company has amended and restated its credit agreement, increasing the secured revolving facility by US$50,000,000 to a total of US$100,000,000, with a three-year term and variable interest rates based on financial ratios. The facility can be expanded by up to an additional US$50,000,000 and can also support general corporate purposes, acquisitions and investments.
The offer is scheduled to expire on March 10, 2026, unless it is extended, varied or withdrawn. Shareholders holding through brokers or other nominees are encouraged to work through those intermediaries if they wish to tender shares into the bid.
Docebo Inc. Schedule 13G/A amendment: affiliated Warburg Pincus entities state they will sell all previously reported Common Shares, with that sale expected to close on 02/27/2026. The Reporting Persons say the November 27, 2025 Agreement of Purchase and Sale ceased to be subject to material closing conditions on 02/09/2026, and this Statement is a voluntary filing.